DHA Responses to Industry on Draft RFP 20200318.pdf

PDF 113 KB Posted

Attached to
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
Solicitation number
HT940220R0002
Issued by
Defense Health Agency

About this file

This document contains responses from the Defense Health Agency (DHA) to industry questions on a draft Request for Proposal (RFP) for the TRICARE Pharmacy Program, 5th Generation.

The DHA addresses questions on conflict of interest, retail network composition, specialty network replenishment, the question and answer process, and requirements and expectations. For the retail network, offerors can employ their preferred approach to meet network access standards and regulatory compliance. Specialty drugs will be replenished where possible through designated pharmacies. The RFP will follow standard question submission and response procedures. Requirements include prescriptive Statement of Work elements, performance-based outcomes, and Statements of Objectives allowing flexibility. Any additional questions should be directed to the provided email address.

View the file

Other files for this federal contract opportunity

Other files attached to DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5), newest first.
File Type Posted
QA CAS Applicability Specific Clauses (May 15 2020).pdf PDF
Responses to Industry on Revised Draft Section C 20200504.pdf PDF
TPharm5 - Overview of Changes to Draft Section C.DOCX DOCX document
Data Pkg 7 Specialty Drug Utilization, Retail and Mail.xlsx XLSX spreadsheet
Data Pkg 14 Retail Claims with COB.xlsx XLSX spreadsheet
Attachment J-5 TPharm5 Award Fee Plan 20191122.docx DOCX document
Data Pkg 5 MOP Utilization by Drug.xlsx XLSX spreadsheet
Data Pkg 23 - Paid Claims and Rejects - MHS GENESIS.xlsx XLSX spreadsheet
Data Pkg 22 - Paid Claims and Rejects - Retail.xlsx XLSX spreadsheet
Data Pkg 24 - CHCBP Volume.xlsx XLSX spreadsheet
Attachment L-9.6 Self-Admin Injectables List.xlsx XLSX spreadsheet
Attachment L-9.7 Expanded Use of MTF and TMOP List.xlsx XLSX spreadsheet
Attachment L-18 CDRL Supplemental Bid Schedule.xlsx XLSX spreadsheet
Attachment L-1 Ordering Instructions for Data Files not on SAM.gov.docx DOCX document
TPharm5 Draft Section L 20191202.docx DOCX document
Data Pkg 25 - OHI Development.xlsx XLSX spreadsheet
Attachment L-9.5 Non-Formulary List.xlsx XLSX spreadsheet
Data Pkg 9 Customer_Service_Volume.xlsx XLSX spreadsheet
Data Pkg 16 VA_VA CHDR Volume.xlsx XLSX spreadsheet
Data Pkg 13 - MTF Claims Volumes by Site.xlsx XLSX spreadsheet
Attachment L-3 Specialty Reimbursement for Use in Determining Incentiv....docx DOCX document
Attachment L-9 Benefit Design Document_TPharm5.xlsx XLSX spreadsheet
Attachment L-2 Retail Network Reimbursement Table.docx DOCX document
TPharm5 Draft RFP READ FIRST 20191202.docx DOCX document
Tpharm5 Draft Section G 20191202.docx DOCX document
Attachment L-8 MMC Sample File.xlsx XLSX spreadsheet
Attachment L-9.8 PA_ST_QL List.XLSX XLSX spreadsheet
Attachment L-4 Negotiated Specialty Retail Replenished Dispensing Fees.docx DOCX document
Attachment L-9.9 Fluoride Products List.xlsx XLSX spreadsheet
Attachment L-12 IHS_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Data Pkg 15 IHS_Pharmacy_Claims_Volume_2017_&_2018.xlsx XLSX spreadsheet
TPharm5 Draft Section E 20191120.docx DOCX document
TPharm5 Draft Section D 20191120.docx DOCX document
Attachment L-1.1 List of Data Packages.docx DOCX document
Attachment L-19 Past Performance Questionnaire Template Tab F 20191120.docx DOCX document
Attachment J-2 Acronym List.docx DOCX document
Attachment J-3 Website Links.docx DOCX document
Attachment L-5 Guaranty_Agreement.pdf PDF
Attachment L-7 Teaming Subcontractor Consent Ltr.docx DOCX document
Attachment L-9.3 Covered OTCs - Purchased Care.xlsx XLSX spreadsheet
Attachment L-19.1 PPI Tool Instructions.docx DOCX document
Data Pkg 3 TRICARE Retail Pharmacy Claim Volume.xlsx XLSX spreadsheet
TPharm5 Draft Section C 20191202.docx DOCX document
Data Pkg 6 - MOP Utilization.xlsx XLSX spreadsheet
Attachment L-13 VA_Pharmacy_Listing_2019.xlsx XLSX spreadsheet
Attachment L-1.2 Non-Disclosure Agreement.docx DOCX document
Data Pkg 21 Enrolled Beneficiary Population.xlsx XLSX spreadsheet
TPharm5 Draft Section H 20191121.docx DOCX document
Data Pkg 10 - Compound Utilizers.xlsx XLSX spreadsheet
TPharm5 Draft Section I 20191120.docx DOCX document
Show all 50

DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

TRICARE Pharmacy Program, 5th Generation Draft Request for Proposal (RFP)

HT9402-20-R-0002

Responses to Industry on Draft RFP 18 March 2020

1) Conflict of Interest If a potential offeror identifies an actual or potential conflict of interest under L.2.13, they are encouraged to engage with the Contracting Offeror immediately to discuss proposed avoidance and/or mitigation strategies for the conflict. An offeror is not precluded from an award if conflicts are properly addressed.

2) Retail Network Composition Government does not dictate the composition of the retail network and the pharmacy reimbursement rates. Offerors are welcome to employ whatever approach they prefer in managing their networks as long as it meets the minimum network access standards and the all network pharmacies at a minimum meet state and federal regulations. The Contractor is also accountable for managing the cost of drugs dispensed in the network under the retail network guarantee included in their proposals.

3) Specialty Network and Replenishment:

Offerors shall maximize the extent to which specialty drugs are replenished. The Offeror shall designate specialty pharmacy(ies) within their network that can receive replenishment.

Replenishment will be owed only for; 1) medications dispensed to TRICARE eligible beneficiaries; 2) medications available for replenishment; 3) medications which are not acquired through the MPPP. These designated pharmacy(ies) will have access to the NPV’s ordering platform to order replenishment and will request replenishment per C.5.8. The replenishing pharmacy(ies) will utilize their own process for validating replenishment received for accuracy and completeness and will account for replenishment still yet to be received.

Not all specialty drugs will be replenished due to limited distribution channels or other factors which may prevent access through the NPV. For non-replenished medications, the costs will be reimbursed and the Contractor’s cost control measures will be incentivized per the specialty network guarantee included in their proposal.

4) Approach to Q&A for the RFP

Once the RFP is posted the Government will accept questions via email. All responses provided by the Government will be posted on beta.SAM.gov for all potential offerors to review. There will be a deadline for a receipt of questions; any questions received after the deadline may not be answered. The Government will attempt to make these responses timely although a specific response time is not known. Any identifying information will be redacted in the posted responses.

5) Approach to Requirements and Expectations from Offerors The approach taken in this RFP is unique in that it contains prescriptive elements typically found in a Statement of Work, performance-based requirements typically found in a Performance Work

Statement, and high level Statements of Objectives. The intent with combining these requirements is to maximize the ability of offerors to apply industry standard practices, the offeror’s proprietary solutions, or other innovative approaches to meet the requirements.

Expectations for offerors are described below.

Statement of Work Requirements: The Government states precisely the services needed to support unique operational needs, specific approaches, tools and processes. Offerors must propose solutions that align with the Government-determined parameters and take responsibility for the requirements.

Performance-Based Requirements: The Government’s outcome-based work statement for performance-based acquisition describes the required results in clear, specific, and objective terms with measureable outcomes. The offeror’s approach is expected to meet the outcomes provided by the Government.

Statements of Objectives: For the identified statements of objectives, the Government is providing overall performance objectives and leaving the requirements to be defined by offerors. Where indicated, offerors must provide a statement of work that includes reporting methods and performance standards that will meet the objectives provided.

This approach allows offerors maximum flexibility to offer unique and innovative solutions and propose metrics best aligned with their approaches.

6) Any additional questions may be directed to our team at:

dha.buckley.acquis-procure.mbx.tpharm5@mail.mil

File details come from the government source that posted it. Updated .